• Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Health Care Facilities & Svcs
  • Sub-Industry: Health Care Services

Genetic Technologies Ltd

+ Add to Watchlist


0.3789 USD 0.0210 5.87%

As of 17:20:00 ET on 12/26/2014.

Snapshot for Genetic Technologies Ltd (GENE)

Open: 0.3501 Day's Range: 0.3435 - 0.3800 Volume: 166,362
Previous Close: 0.3579 52wk Range: 0.3100 - 2.4100 1-Yr Rtn: -75.55%

Stock Chart for GENE

No chart data available.
  • GENE:US 0.3789
  • 1D
  • 1M
  • 1Y
Interactive GENE Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for GENE

Current P/E Ratio (ttm) -
Estimated P/E(06/2015) -
Relative P/E vs. SPX -
Earnings Per Share (AUD) (ttm) -
Est. EPS (AUD) (06/2015) -0.4350
Est. PEG Ratio -
Market Cap (M USD) 10.37
Shares Outstanding (M) 27.36
30 Day Average Volume 465,716
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 02/20/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for GENE

  • Revenue
  • Net Income (M/AUD)
  • Profit Margin (%)

Company Profile & Key Executives for GENE

Genetic Technologies Limited is a biotechnology company which does advanced DNA genetic research and testing. The Company has several gene-based patents which include intron sequence analysis, genomic mapping and fetal cell recovery. Genetic also operates a testing laboratory that performs disputed paternity testing by DNA techniques.

Alison J MewChief Executive OfficerEutillio BuccilliCFO/COO
Mark OstrowskiSenior VP/Pres:PhenogenRichard AllmanDir:Scientific
More Company Profile & Key Executives for GENE

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil